The research burden of randomized controlled trial participation: a systematic thematic synthesis of qualitative evidence

Background Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this research burden (i.e., the psychological, physical, and financial burdens) experienced by patients through their participation in a RC...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMC medicine Jg. 18; H. 1; S. 6 - 11
Hauptverfasser:	Naidoo, Nivantha, Nguyen, Van Thu, Ravaud, Philippe, Young, Bridget, Amiel, Philippe, Schanté, Daniel, Clarke, Mike, Boutron, Isabelle
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	London BioMed Central 20.01.2020 BioMed Central Ltd Springer Nature B.V BMC
Schlagworte:	Anxiety Biomedicine Clinical trials Codes Consent Cost of Illness Data collection Depression (Mood disorder) Economic aspects Finance Guinea pigs Humans Life Sciences Medical research Medicine Medicine & Public Health Methods Participation Patients Physiological aspects Psychological aspects Psychological research Public opinion Qualitative analysis Qualitative Research Quality assessment Randomization Randomized controlled trials Randomized Controlled Trials as Topic Research Article Research burden Santé publique et épidémiologie Trial participation Volunteers - psychology France Trial participation Research burden Randomized controlled trials
ISSN:	1741-7015, 1741-7015
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Abstract	Background Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this research burden (i.e., the psychological, physical, and financial burdens) experienced by patients through their participation in a RCT. Methods We conducted a systematic review of qualitative studies exploring adult patients’ experiences with RCT participation. We searched MEDLINE (PubMed), CINAHL, PSYCHINFO, and Embase (search date March 2018) for eligible reports. Qualitative data coding and indexing were assisted by NVivo. The quality of reports was assessed by using the Critical Appraisal Skills Program (CASP) tool. Results We included 45 qualitative studies that involved 1732 RCT participants. Important psychological burdens were identified at every stage of the trial process. Participants reported feeling anxiety and being afraid of “being a ‘guinea pig’” and described undergoing randomization and allocation to a placebo as particularly difficult resulting in disappointment, anger, and depression. Patients’ follow-up and trial closure were also responsible for a wide range of psychological, physical, and financial burdens. Furthermore, factors related to burdensome impacts and consequences were discerned. These factors involved trial information, poorly organized and too-demanding follow-up, and lack of appropriate management when the patient’s participation ended. Trial participation was also associated with beneficial effects such as the satisfaction of feeling “useful,” gaining “a sense of control,” and receiving special attention. Conclusions Our finding provides a detailed description of research burden across the whole RCT process. Many of the burdens described could be anticipated, and some avoided in a movement toward minimally disruptive clinical research. Such an approach could improve trial recruitment and retention. Review registration PROSPERO CRD42018098994
AbstractList	Background Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this research burden (i.e., the psychological, physical, and financial burdens) experienced by patients through their participation in a RCT. Methods We conducted a systematic review of qualitative studies exploring adult patients' experiences with RCT participation. We searched MEDLINE (PubMed), CINAHL, PSYCHINFO, and Embase (search date March 2018) for eligible reports. Qualitative data coding and indexing were assisted by NVivo. The quality of reports was assessed by using the Critical Appraisal Skills Program (CASP) tool. Results We included 45 qualitative studies that involved 1732 RCT participants. Important psychological burdens were identified at every stage of the trial process. Participants reported feeling anxiety and being afraid of "being a 'guinea pig'" and described undergoing randomization and allocation to a placebo as particularly difficult resulting in disappointment, anger, and depression. Patients' follow-up and trial closure were also responsible for a wide range of psychological, physical, and financial burdens. Furthermore, factors related to burdensome impacts and consequences were discerned. These factors involved trial information, poorly organized and too-demanding follow-up, and lack of appropriate management when the patient's participation ended. Trial participation was also associated with beneficial effects such as the satisfaction of feeling "useful," gaining "a sense of control," and receiving special attention. Conclusions Our finding provides a detailed description of research burden across the whole RCT process. Many of the burdens described could be anticipated, and some avoided in a movement toward minimally disruptive clinical research. Such an approach could improve trial recruitment and retention. Review registration PROSPERO CRD42018098994 Keywords: Randomized controlled trials, Research burden, Trial participation Background Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this research burden (i.e., the psychological, physical, and financial burdens) experienced by patients through their participation in a RCT. Methods We conducted a systematic review of qualitative studies exploring adult patients’ experiences with RCT participation. We searched MEDLINE (PubMed), CINAHL, PSYCHINFO, and Embase (search date March 2018) for eligible reports. Qualitative data coding and indexing were assisted by NVivo. The quality of reports was assessed by using the Critical Appraisal Skills Program (CASP) tool. Results We included 45 qualitative studies that involved 1732 RCT participants. Important psychological burdens were identified at every stage of the trial process. Participants reported feeling anxiety and being afraid of “being a ‘guinea pig’” and described undergoing randomization and allocation to a placebo as particularly difficult resulting in disappointment, anger, and depression. Patients’ follow-up and trial closure were also responsible for a wide range of psychological, physical, and financial burdens. Furthermore, factors related to burdensome impacts and consequences were discerned. These factors involved trial information, poorly organized and too-demanding follow-up, and lack of appropriate management when the patient’s participation ended. Trial participation was also associated with beneficial effects such as the satisfaction of feeling “useful,” gaining “a sense of control,” and receiving special attention. Conclusions Our finding provides a detailed description of research burden across the whole RCT process. Many of the burdens described could be anticipated, and some avoided in a movement toward minimally disruptive clinical research. Such an approach could improve trial recruitment and retention. Review registration PROSPERO CRD42018098994 Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this research burden (i.e., the psychological, physical, and financial burdens) experienced by patients through their participation in a RCT. We conducted a systematic review of qualitative studies exploring adult patients' experiences with RCT participation. We searched MEDLINE (PubMed), CINAHL, PSYCHINFO, and Embase (search date March 2018) for eligible reports. Qualitative data coding and indexing were assisted by NVivo. The quality of reports was assessed by using the Critical Appraisal Skills Program (CASP) tool. We included 45 qualitative studies that involved 1732 RCT participants. Important psychological burdens were identified at every stage of the trial process. Participants reported feeling anxiety and being afraid of "being a 'guinea pig'" and described undergoing randomization and allocation to a placebo as particularly difficult resulting in disappointment, anger, and depression. Patients' follow-up and trial closure were also responsible for a wide range of psychological, physical, and financial burdens. Furthermore, factors related to burdensome impacts and consequences were discerned. These factors involved trial information, poorly organized and too-demanding follow-up, and lack of appropriate management when the patient's participation ended. Trial participation was also associated with beneficial effects such as the satisfaction of feeling "useful," gaining "a sense of control," and receiving special attention. Our finding provides a detailed description of research burden across the whole RCT process. Many of the burdens described could be anticipated, and some avoided in a movement toward minimally disruptive clinical research. Such an approach could improve trial recruitment and retention. Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this research burden (i.e., the psychological, physical, and financial burdens) experienced by patients through their participation in a RCT.BACKGROUNDParticipation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this research burden (i.e., the psychological, physical, and financial burdens) experienced by patients through their participation in a RCT.We conducted a systematic review of qualitative studies exploring adult patients' experiences with RCT participation. We searched MEDLINE (PubMed), CINAHL, PSYCHINFO, and Embase (search date March 2018) for eligible reports. Qualitative data coding and indexing were assisted by NVivo. The quality of reports was assessed by using the Critical Appraisal Skills Program (CASP) tool.METHODSWe conducted a systematic review of qualitative studies exploring adult patients' experiences with RCT participation. We searched MEDLINE (PubMed), CINAHL, PSYCHINFO, and Embase (search date March 2018) for eligible reports. Qualitative data coding and indexing were assisted by NVivo. The quality of reports was assessed by using the Critical Appraisal Skills Program (CASP) tool.We included 45 qualitative studies that involved 1732 RCT participants. Important psychological burdens were identified at every stage of the trial process. Participants reported feeling anxiety and being afraid of "being a 'guinea pig'" and described undergoing randomization and allocation to a placebo as particularly difficult resulting in disappointment, anger, and depression. Patients' follow-up and trial closure were also responsible for a wide range of psychological, physical, and financial burdens. Furthermore, factors related to burdensome impacts and consequences were discerned. These factors involved trial information, poorly organized and too-demanding follow-up, and lack of appropriate management when the patient's participation ended. Trial participation was also associated with beneficial effects such as the satisfaction of feeling "useful," gaining "a sense of control," and receiving special attention.RESULTSWe included 45 qualitative studies that involved 1732 RCT participants. Important psychological burdens were identified at every stage of the trial process. Participants reported feeling anxiety and being afraid of "being a 'guinea pig'" and described undergoing randomization and allocation to a placebo as particularly difficult resulting in disappointment, anger, and depression. Patients' follow-up and trial closure were also responsible for a wide range of psychological, physical, and financial burdens. Furthermore, factors related to burdensome impacts and consequences were discerned. These factors involved trial information, poorly organized and too-demanding follow-up, and lack of appropriate management when the patient's participation ended. Trial participation was also associated with beneficial effects such as the satisfaction of feeling "useful," gaining "a sense of control," and receiving special attention.Our finding provides a detailed description of research burden across the whole RCT process. Many of the burdens described could be anticipated, and some avoided in a movement toward minimally disruptive clinical research. Such an approach could improve trial recruitment and retention.CONCLUSIONSOur finding provides a detailed description of research burden across the whole RCT process. Many of the burdens described could be anticipated, and some avoided in a movement toward minimally disruptive clinical research. Such an approach could improve trial recruitment and retention.PROSPERO CRD42018098994.REVIEW REGISTRATIONPROSPERO CRD42018098994. Background Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this research burden (i.e., the psychological, physical, and financial burdens) experienced by patients through their participation in a RCT. Methods We conducted a systematic review of qualitative studies exploring adult patients’ experiences with RCT participation. We searched MEDLINE (PubMed), CINAHL, PSYCHINFO, and Embase (search date March 2018) for eligible reports. Qualitative data coding and indexing were assisted by NVivo. The quality of reports was assessed by using the Critical Appraisal Skills Program (CASP) tool. Results We included 45 qualitative studies that involved 1732 RCT participants. Important psychological burdens were identified at every stage of the trial process. Participants reported feeling anxiety and being afraid of “being a ‘guinea pig’” and described undergoing randomization and allocation to a placebo as particularly difficult resulting in disappointment, anger, and depression. Patients’ follow-up and trial closure were also responsible for a wide range of psychological, physical, and financial burdens. Furthermore, factors related to burdensome impacts and consequences were discerned. These factors involved trial information, poorly organized and too-demanding follow-up, and lack of appropriate management when the patient’s participation ended. Trial participation was also associated with beneficial effects such as the satisfaction of feeling “useful,” gaining “a sense of control,” and receiving special attention. Conclusions Our finding provides a detailed description of research burden across the whole RCT process. Many of the burdens described could be anticipated, and some avoided in a movement toward minimally disruptive clinical research. Such an approach could improve trial recruitment and retention. Review registration PROSPERO CRD42018098994 Abstract Background Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this research burden (i.e., the psychological, physical, and financial burdens) experienced by patients through their participation in a RCT. Methods We conducted a systematic review of qualitative studies exploring adult patients’ experiences with RCT participation. We searched MEDLINE (PubMed), CINAHL, PSYCHINFO, and Embase (search date March 2018) for eligible reports. Qualitative data coding and indexing were assisted by NVivo. The quality of reports was assessed by using the Critical Appraisal Skills Program (CASP) tool. Results We included 45 qualitative studies that involved 1732 RCT participants. Important psychological burdens were identified at every stage of the trial process. Participants reported feeling anxiety and being afraid of “being a ‘guinea pig’” and described undergoing randomization and allocation to a placebo as particularly difficult resulting in disappointment, anger, and depression. Patients’ follow-up and trial closure were also responsible for a wide range of psychological, physical, and financial burdens. Furthermore, factors related to burdensome impacts and consequences were discerned. These factors involved trial information, poorly organized and too-demanding follow-up, and lack of appropriate management when the patient’s participation ended. Trial participation was also associated with beneficial effects such as the satisfaction of feeling “useful,” gaining “a sense of control,” and receiving special attention. Conclusions Our finding provides a detailed description of research burden across the whole RCT process. Many of the burdens described could be anticipated, and some avoided in a movement toward minimally disruptive clinical research. Such an approach could improve trial recruitment and retention. Review registration PROSPERO CRD42018098994 Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this research burden (i.e., the psychological, physical, and financial burdens) experienced by patients through their participation in a RCT. We conducted a systematic review of qualitative studies exploring adult patients' experiences with RCT participation. We searched MEDLINE (PubMed), CINAHL, PSYCHINFO, and Embase (search date March 2018) for eligible reports. Qualitative data coding and indexing were assisted by NVivo. The quality of reports was assessed by using the Critical Appraisal Skills Program (CASP) tool. We included 45 qualitative studies that involved 1732 RCT participants. Important psychological burdens were identified at every stage of the trial process. Participants reported feeling anxiety and being afraid of "being a 'guinea pig'" and described undergoing randomization and allocation to a placebo as particularly difficult resulting in disappointment, anger, and depression. Patients' follow-up and trial closure were also responsible for a wide range of psychological, physical, and financial burdens. Furthermore, factors related to burdensome impacts and consequences were discerned. These factors involved trial information, poorly organized and too-demanding follow-up, and lack of appropriate management when the patient's participation ended. Trial participation was also associated with beneficial effects such as the satisfaction of feeling "useful," gaining "a sense of control," and receiving special attention. Our finding provides a detailed description of research burden across the whole RCT process. Many of the burdens described could be anticipated, and some avoided in a movement toward minimally disruptive clinical research. Such an approach could improve trial recruitment and retention. PROSPERO CRD42018098994. Background: Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this research burden (i.e., the psychological, physical, and financial burdens) experienced by patients through their participation in a RCT.Methods: We conducted a systematic review of qualitative studies exploring adult patients' experiences with RCT participation. We searched MEDLINE (PubMed), CINAHL, PSYCHINFO, and Embase (search date March 2018) for eligible reports. Qualitative data coding and indexing were assisted by NVivo. The quality of reports was assessed by using the Critical Appraisal Skills Program (CASP) tool.Results: We included 45 qualitative studies that involved 1732 RCT participants. Important psychological burdens were identified at every stage of the trial process. Participants reported feeling anxiety and being afraid of "being a 'guinea pig'" and described undergoing randomization and allocation to a placebo as particularly difficult resulting in disappointment, anger, and depression. Patients' follow-up and trial closure were also responsible for a wide range of psychological, physical, and financial burdens. Furthermore, factors related to burdensome impacts and consequences were discerned. These factors involved trial information, poorly organized and too-demanding follow-up, and lack of appropriate management when the patient's participation ended. Trial participation was also associated with beneficial effects such as the satisfaction of feeling "useful," gaining "a sense of control," and receiving special attention.Conclusions: Our finding provides a detailed description of research burden across the whole RCT process. Many of the burdens described could be anticipated, and some avoided in a movement toward minimally disruptive clinical research. Such an approach could improve trial recruitment and retention.
ArticleNumber	6
Audience	Academic
Author	Young, Bridget Ravaud, Philippe Boutron, Isabelle Nguyen, Van Thu Amiel, Philippe Clarke, Mike Schanté, Daniel Naidoo, Nivantha
Author_xml	– sequence: 1 givenname: Nivantha surname: Naidoo fullname: Naidoo, Nivantha organization: Université de Paris, CRESS, INSERM, INRA, Centre d’Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu – sequence: 2 givenname: Van Thu surname: Nguyen fullname: Nguyen, Van Thu organization: Université de Paris, CRESS, INSERM, INRA, Department of Health Services Research, Institute of Population Health Sciences, University of Liverpool – sequence: 3 givenname: Philippe surname: Ravaud fullname: Ravaud, Philippe organization: Université de Paris, CRESS, INSERM, INRA, Centre d’Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu, Department of Epidemiology, Mailman School of Public Health, Columbia University – sequence: 4 givenname: Bridget surname: Young fullname: Young, Bridget organization: Department of Health Services Research, Institute of Population Health Sciences, University of Liverpool – sequence: 5 givenname: Philippe surname: Amiel fullname: Amiel, Philippe organization: INSERM U 1123 ECEVE (Clinical Epidemiology, Economic, Evaluation, Vulnerable populations), University Paris Diderot – sequence: 6 givenname: Daniel surname: Schanté fullname: Schanté, Daniel organization: Jusqu’A La Mort Accompagner la Vie (JALMALV), Comité des Utilisateurs et Professionnels, Institut National du Cancer (INCa) – sequence: 7 givenname: Mike surname: Clarke fullname: Clarke, Mike organization: Queen’s University Belfast School of Medicine Dentistry and Biomedical Sciences – sequence: 8 givenname: Isabelle surname: Boutron fullname: Boutron, Isabelle email: isabelle.boutron@aphp.fr organization: Université de Paris, CRESS, INSERM, INRA, Centre d’Epidémiologie Clinique, AP-HP, Hôpital Hôtel Dieu
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/31955710$$D View this record in MEDLINE/PubMed https://hal.science/hal-02546706$$DView record in HAL
BookMark	eNp9Uk2P0zAQjdAi9gN-ABcUCQnBIYsnX3Y4IK1WwK5Uictythx73LhK4q6dVCq_HqcpS1sByiHjyXtvPC_vMjrrbY9R9BrINQArP3pIKygTAlUCOS2T4ll0ATSHhBIozg7q8-jS-xUhaUFp_iI6z6AqCgrkIto-NBg79CicbOJ6dAr72OrYiV7ZzvxEFUvbD862bSgHZ0Qbr4UbjDRrMRjbf4pF7Ld-wC4cZTw0-8Jv-1B74ye1x1G0Zgj9Dca4MWGGxJfRcy1aj6_276vox9cvD7d3yeL7t_vbm0UiaZYPSV0XlBAoJcmghrAqqYjSNSoFtS6Z0jmIOmWCpVCwSldMAxaVEpXWMlOMZFfR_ayrrFjxtTOdcFtuheG7hnVLvtunRS4A6qwkkoDWeaq0KBkhhDJNSlEziUHr86y1HusOlcTgjGiPRI-_9KbhS7vhZUVJyrIg8GEWaE5odzcLPvXCL8pLSsoNBOz7_TBnH0f0A--Ml9i2okc7ep5meZoVjKQT9O0JdGVH1wdbA6qgGeT5zok9ainCsqbXNtxRTqL8pgRG03DFSev6L6jwKOxMyAJqE_pHhHcHhAZFOzTetuOUDn8MfHPo3tP-v9MYADADpLPeO9RPECB8SjyfE89DDPiUeF4EDj3hyF3SptAK0_6Xmc5MH6b0S3R_TPs36RdV5RPi
CitedBy_id	crossref_primary_10_1186_s12936_020_03279_5 crossref_primary_10_1007_s41649_023_00247_4 crossref_primary_10_3389_fneur_2021_675520 crossref_primary_10_1136_bmjopen_2020_043364 crossref_primary_10_1007_s40732_023_00566_w crossref_primary_10_1177_26320843221128296 crossref_primary_10_1200_OP_24_00334 crossref_primary_10_1016_j_cct_2021_106665 crossref_primary_10_1002_hast_4938 crossref_primary_10_1016_j_childyouth_2023_107266 crossref_primary_10_1016_j_nmd_2023_12_014 crossref_primary_10_1093_crocol_otad019 crossref_primary_10_2196_25743 crossref_primary_10_3390_ijerph18052611 crossref_primary_10_1186_s12916_024_03707_2 crossref_primary_10_1186_s13063_021_05233_5 crossref_primary_10_1177_09589287241284780 crossref_primary_10_1002_rfc2_48 crossref_primary_10_1186_s12883_020_01936_5 crossref_primary_10_1186_s13063_025_08846_2 crossref_primary_10_1016_j_jchf_2024_08_024 crossref_primary_10_2196_63627 crossref_primary_10_1016_j_cct_2021_106399 crossref_primary_10_1136_bmjopen_2025_101326 crossref_primary_10_1038_s41591_023_02489_z crossref_primary_10_1080_23294515_2025_2526339 crossref_primary_10_1186_s12966_023_01481_7 crossref_primary_10_1007_s40120_020_00229_w crossref_primary_10_1177_13591053221141131 crossref_primary_10_1371_journal_pone_0250698 crossref_primary_10_12968_bjon_2025_0021 crossref_primary_10_1186_s13063_020_04902_1 crossref_primary_10_1542_peds_2022_058067 crossref_primary_10_3390_su132212642 crossref_primary_10_1016_j_tipsro_2022_10_005 crossref_primary_10_2147_CMAR_S447407 crossref_primary_10_1016_j_psyneuen_2024_107058 crossref_primary_10_1177_17423953211060253 crossref_primary_10_1111_jep_13669 crossref_primary_10_1186_s13063_025_08850_6 crossref_primary_10_1001_jamanetworkopen_2023_33642 crossref_primary_10_1177_17407745241296864 crossref_primary_10_3390_healthcare10020356 crossref_primary_10_1155_2022_3540271 crossref_primary_10_2196_29691 crossref_primary_10_7748_cnp_2025_e1884 crossref_primary_10_1016_j_drugalcdep_2024_111368 crossref_primary_10_1016_j_jclinepi_2025_111813 crossref_primary_10_1186_s13063_021_05455_7 crossref_primary_10_1188_21_CJON_647_654 crossref_primary_10_1186_s13063_025_08731_y crossref_primary_10_1016_j_conctc_2023_101079 crossref_primary_10_1016_j_jclinepi_2020_04_021 crossref_primary_10_1016_j_conctc_2022_100987 crossref_primary_10_1080_15265161_2023_2296404 crossref_primary_10_1136_bmjopen_2021_055521 crossref_primary_10_1177_15459683251369467 crossref_primary_10_1371_journal_pone_0322118 crossref_primary_10_1080_10447318_2025_2490400 crossref_primary_10_1177_1609406921993276 crossref_primary_10_1212_WNL_0000000000209503 crossref_primary_10_1007_s10903_024_01632_3 crossref_primary_10_1186_s42238_021_00089_7 crossref_primary_10_1016_j_drugalcdep_2022_109390 crossref_primary_10_1016_j_jpainsymman_2025_08_032 crossref_primary_10_1097_WON_0000000000000979 crossref_primary_10_1186_s12916_022_02594_9 crossref_primary_10_1186_s13063_022_06470_y crossref_primary_10_2147_COPD_S525781 crossref_primary_10_1177_16094069211009679 crossref_primary_10_1111_hex_13304 crossref_primary_10_1161_STROKEAHA_120_033227 crossref_primary_10_1007_s43441_025_00760_8 crossref_primary_10_1080_03036758_2025_2525222 crossref_primary_10_3390_cancers14041075 crossref_primary_10_1016_j_advnut_2023_100156 crossref_primary_10_1007_s13311_022_01292_x crossref_primary_10_1016_S2215_0366_22_00041_4 crossref_primary_10_1093_ageing_afac090 crossref_primary_10_1371_journal_pmed_1004405 crossref_primary_10_2196_23979 crossref_primary_10_1007_s43441_024_00658_x crossref_primary_10_1542_peds_2020_042903 crossref_primary_10_1038_s41746_023_00767_1 crossref_primary_10_2196_26004 crossref_primary_10_1200_GO_23_00349
Cites_doi	10.1177/1556264614545037 10.2307/3563957 10.1186/s13063-018-2535-5 10.1001/jama.289.24.3243 10.1186/s13643-016-0240-6 10.1136/bmj.k3193 10.1136/bmj.311.6997.109 10.1634/theoncologist.2017-0628 10.1186/1471-2288-4-5 10.1016/S0895-4356(99)00141-9 10.1136/bmjopen-2011-000496 10.1093/ije/dyp174 10.1016/j.jclinepi.2017.10.023 10.1371/journal.pmed.1000097 10.1186/s13063-018-2544-4 10.1634/theoncologist.2015-0068 10.1186/1471-2288-9-24 10.1016/S0140-6736(04)17670-8 10.1186/s12913-014-0579-0 10.1016/j.socscimed.2004.11.023 10.1200/JCO.2005.00.141 10.1186/1471-2288-8-45 10.1186/1745-6215-7-9 10.1093/jnci/djw315 10.1136/bmj.i6262 10.1136/bmjopen-2018-021959 10.7326/0003-4819-137-1-200207020-00007 10.1136/bmj.f2304 10.1186/s13643-016-0249-x 10.1016/S1470-2045(06)70576-9 10.1016/j.jclinepi.2017.06.020 10.2307/3564537 10.1080/17482620802646204 10.1177/1740774513491337 10.1186/1745-6215-10-52 10.1186/1472-6963-14-89 10.1186/1471-2288-12-181 10.1136/bmj.307.6913.1199 10.1001/jama.294.17.2203 10.1001/jamanetworkopen.2018.2969 10.1136/bmj.c1066 10.1002/art.24279 10.1111/jep.12805 10.1186/s40900-018-0129-8
ContentType	Journal Article
Copyright	The Author(s). 2020 COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Attribution
Copyright_xml	– notice: The Author(s). 2020 – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Attribution
DBID	C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7U9 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P M7N PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 1XC VOOES 5PM DOA
DOI	10.1186/s12916-019-1476-5
DatabaseName	Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	Publicly Available Content Database MEDLINE - Academic MEDLINE
Database_xml	– sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content (ProQuest) url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine
EISSN	1741-7015
EndPage	11
ExternalDocumentID	oai_doaj_org_article_a11b360c01ff42dfa6800078f06ab8ce PMC6970283 oai:HAL:hal-02546706v1 A618720281 31955710 10_1186_s12916_019_1476_5
Genre	Research Support, Non-U.S. Gov't Systematic Review Journal Article
GeographicLocations	France
GeographicLocations_xml	– name: France
GrantInformation_xml	– fundername: Institut National Du Cancer funderid: http://dx.doi.org/10.13039/501100006364 – fundername: Department of Health grantid: 08/249/01 – fundername: Medical Research Council grantid: G0901530 – fundername: ;
GroupedDBID	--- 0R~ 23N 2WC 4.4 53G 5GY 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 MK0 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7QL 7U9 7XB 8FK AZQEC C1K DWQXO H94 K9. M7N PKEHL PQEST PQUKI PRINS 7X8 1XC 2VQ AHSBF C1A EJD H13 IPNFZ RIG VOOES 5PM
ID	FETCH-LOGICAL-c734t-bb570016c031b1019090dfbedd1bf68df41ab28a821589f98f1e59da9ffc3d803
IEDL.DBID	DOA
ISICitedReferencesCount	91
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000513668200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1741-7015
IngestDate	Mon Nov 10 04:23:27 EST 2025 Tue Nov 04 02:04:53 EST 2025 Tue Oct 14 20:14:26 EDT 2025 Thu Oct 02 06:42:17 EDT 2025 Wed Oct 08 14:21:42 EDT 2025 Tue Nov 11 10:41:08 EST 2025 Tue Nov 04 17:53:25 EST 2025 Thu May 22 21:21:40 EDT 2025 Mon Jul 21 06:05:07 EDT 2025 Sat Nov 29 04:08:19 EST 2025 Tue Nov 18 21:52:33 EST 2025 Sat Sep 06 07:29:21 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	1
Keywords	Trial participation Research burden Randomized controlled trials
Language	English
License	Attribution: http://creativecommons.org/licenses/by Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c734t-bb570016c031b1019090dfbedd1bf68df41ab28a821589f98f1e59da9ffc3d803
Notes	ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 PMCID: PMC6970283
ORCID	0000-0003-4557-9266 0000-0001-8264-9206
OpenAccessLink	https://doaj.org/article/a11b360c01ff42dfa6800078f06ab8ce
PMID	31955710
PQID	2357314480
PQPubID	42775
PageCount	11
ParticipantIDs	doaj_primary_oai_doaj_org_article_a11b360c01ff42dfa6800078f06ab8ce pubmedcentral_primary_oai_pubmedcentral_nih_gov_6970283 hal_primary_oai_HAL_hal_02546706v1 proquest_miscellaneous_2342358021 proquest_journals_2357314480 gale_infotracmisc_A618720281 gale_infotracacademiconefile_A618720281 gale_healthsolutions_A618720281 pubmed_primary_31955710 crossref_primary_10_1186_s12916_019_1476_5 crossref_citationtrail_10_1186_s12916_019_1476_5 springer_journals_10_1186_s12916_019_1476_5
PublicationCentury	2000
PublicationDate	2020-01-20
PublicationDateYYYYMMDD	2020-01-20
PublicationDate_xml	– month: 01 year: 2020 text: 2020-01-20 day: 20
PublicationDecade	2020
PublicationPlace	London
PublicationPlace_xml	– name: London – name: England
PublicationTitle	BMC medicine
PublicationTitleAbbrev	BMC Med
PublicationTitleAlternate	BMC Med
PublicationYear	2020
Publisher	BioMed Central BioMed Central Ltd Springer Nature B.V BMC
Publisher_xml	– name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC
References	1476_CR24 E O'Leary (1476_CR46) 2013; 10 N Ahmad (1476_CR35) 2009; 61 JH Lingler (1476_CR17) 2014; 9 P Healy (1476_CR23) 2018; 19 PM Rothwell (1476_CR34) 2005; 365 JP Domecq (1476_CR48) 2014; 14 VC Brueton (1476_CR6) 2013; 12 VM Montori (1476_CR33) 2005; 294 RD Nipp (1476_CR2) 2015; 20 A Price (1476_CR50) 2018; 24 OM Dekkers (1476_CR36) 2009; 39 Jane Noyes (1476_CR52) 2018; 97 S Ross (1476_CR26) 1999; 52 A Dechartres (1476_CR32) 2013; 346 V Montori (1476_CR45) 2017 A Anderson (1476_CR22) 2018; 1 RL Shaw (1476_CR13) 2004; 4 S Treweek (1476_CR5) 2018; 2 B Fletcher (1476_CR29) 2012; 2 1476_CR39 DE Rolfe (1476_CR49) 2018; 4 HT Borno (1476_CR51) 2018; 23 CM Ulrich (1476_CR18) 2005; 27 A Booth (1476_CR16) 2016; 5 EJ Mills (1476_CR25) 2006; 7 DS Shimm (1476_CR30) 1992; 14 R Youngson (1476_CR41) 2016; 355 N Mays (1476_CR19) 1995; 311 JH Lingler (1476_CR21) 2014; 9 JF Caron-Flinterman (1476_CR47) 2005; 60 RT Chlebowski (1476_CR1) 2003; 289 ZC Skea (1476_CR7) 2019; 9 D Evans (1476_CR14) 2002; 90 CP Gross (1476_CR27) 2002; 137 CA Townsley (1476_CR4) 2005; 23 J Thomas (1476_CR8) 2008; 8 AM McDonald (1476_CR28) 2006; 7 L Todres (1476_CR40) 2009; 4 JS Tobias (1476_CR38) 1993; 307 B Verboom (1476_CR20) 2016; 5 1476_CR9 S Treweek (1476_CR42) 2018; 19 P Wicks (1476_CR44) 2018; 362 A Tong (1476_CR11) 2012; 12 AM Methley (1476_CR12) 2014; 14 C Relton (1476_CR43) 2010; 340 1476_CR3 M Ethgen (1476_CR37) 2009; 9 M Toerien (1476_CR31) 2009; 10 1476_CR15 D Moher (1476_CR10) 2009; 6
References_xml	– volume: 9 start-page: 46 issue: 4 year: 2014 ident: 1476_CR21 publication-title: J Empir Res Hum Res Ethics doi: 10.1177/1556264614545037 – volume: 27 start-page: 17 issue: 4 year: 2005 ident: 1476_CR18 publication-title: IRB doi: 10.2307/3563957 – volume: 19 start-page: 139 issue: 1 year: 2018 ident: 1476_CR42 publication-title: Trials doi: 10.1186/s13063-018-2535-5 – volume: 289 start-page: 3243 issue: 24 year: 2003 ident: 1476_CR1 publication-title: JAMA doi: 10.1001/jama.289.24.3243 – volume: 9 start-page: 46 issue: 4 year: 2014 ident: 1476_CR17 publication-title: JERHRE doi: 10.1177/1556264614545037 – volume: 5 start-page: 61 year: 2016 ident: 1476_CR20 publication-title: Syst Rev doi: 10.1186/s13643-016-0240-6 – volume: 362 start-page: k3193 year: 2018 ident: 1476_CR44 publication-title: BMJ doi: 10.1136/bmj.k3193 – ident: 1476_CR39 – volume: 311 start-page: 109 issue: 6997 year: 1995 ident: 1476_CR19 publication-title: Br Med J doi: 10.1136/bmj.311.6997.109 – volume: 23 start-page: 1242 issue: 10 year: 2018 ident: 1476_CR51 publication-title: Oncologist doi: 10.1634/theoncologist.2017-0628 – volume: 4 start-page: 5 year: 2004 ident: 1476_CR13 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-4-5 – volume: 52 start-page: 1143 issue: 12 year: 1999 ident: 1476_CR26 publication-title: J Clin Epidemiol doi: 10.1016/S0895-4356(99)00141-9 – volume: 2 issue: 1 year: 2012 ident: 1476_CR29 publication-title: BMJ Open doi: 10.1136/bmjopen-2011-000496 – volume: 39 start-page: 89 issue: 1 year: 2009 ident: 1476_CR36 publication-title: Int J Epidemiol doi: 10.1093/ije/dyp174 – ident: 1476_CR9 doi: 10.1016/j.jclinepi.2017.10.023 – volume: 6 issue: 7 year: 2009 ident: 1476_CR10 publication-title: PLoS Med doi: 10.1371/journal.pmed.1000097 – volume: 19 start-page: 147 issue: 1 year: 2018 ident: 1476_CR23 publication-title: Trials doi: 10.1186/s13063-018-2544-4 – volume: 20 start-page: 572 issue: 6 year: 2015 ident: 1476_CR2 publication-title: Oncologist doi: 10.1634/theoncologist.2015-0068 – ident: 1476_CR24 – volume: 9 start-page: 24 year: 2009 ident: 1476_CR37 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-9-24 – volume: 365 start-page: 82 issue: 9453 year: 2005 ident: 1476_CR34 publication-title: Lancet doi: 10.1016/S0140-6736(04)17670-8 – volume: 14 start-page: 579 year: 2014 ident: 1476_CR12 publication-title: BMC Health Serv Res doi: 10.1186/s12913-014-0579-0 – volume: 60 start-page: 2575 issue: 11 year: 2005 ident: 1476_CR47 publication-title: Soc Sci Med doi: 10.1016/j.socscimed.2004.11.023 – volume: 23 start-page: 3112 issue: 13 year: 2005 ident: 1476_CR4 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.00.141 – volume: 12 year: 2013 ident: 1476_CR6 publication-title: Cochrane Database Syst Rev – volume: 2 year: 2018 ident: 1476_CR5 publication-title: Cochrane Database Syst Rev – volume: 8 start-page: 45 year: 2008 ident: 1476_CR8 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-8-45 – volume: 7 start-page: 9 year: 2006 ident: 1476_CR28 publication-title: Trials doi: 10.1186/1745-6215-7-9 – ident: 1476_CR3 doi: 10.1093/jnci/djw315 – volume: 355 start-page: i6262 year: 2016 ident: 1476_CR41 publication-title: BMJ doi: 10.1136/bmj.i6262 – volume: 9 issue: 6 year: 2019 ident: 1476_CR7 publication-title: BMJ Open doi: 10.1136/bmjopen-2018-021959 – volume: 137 start-page: 10 issue: 1 year: 2002 ident: 1476_CR27 publication-title: Ann Intern Med doi: 10.7326/0003-4819-137-1-200207020-00007 – volume: 346 start-page: f2304 year: 2013 ident: 1476_CR32 publication-title: BMJ doi: 10.1136/bmj.f2304 – volume: 5 start-page: 74 year: 2016 ident: 1476_CR16 publication-title: Syst Rev doi: 10.1186/s13643-016-0249-x – volume: 7 start-page: 141 issue: 2 year: 2006 ident: 1476_CR25 publication-title: Lancet Oncol doi: 10.1016/S1470-2045(06)70576-9 – volume: 97 start-page: 49 year: 2018 ident: 1476_CR52 publication-title: Journal of Clinical Epidemiology doi: 10.1016/j.jclinepi.2017.06.020 – volume: 90 start-page: 290 issue: 3 year: 2002 ident: 1476_CR14 publication-title: J Med Library Association – volume: 14 start-page: 7 issue: 2 year: 1992 ident: 1476_CR30 publication-title: IRB doi: 10.2307/3564537 – volume: 4 start-page: 68 issue: 2 year: 2009 ident: 1476_CR40 publication-title: Int J Qual Stud Health Well Being doi: 10.1080/17482620802646204 – volume: 10 start-page: 624 issue: 4 year: 2013 ident: 1476_CR46 publication-title: Clin Trials doi: 10.1177/1740774513491337 – volume: 10 start-page: 52 year: 2009 ident: 1476_CR31 publication-title: Trials doi: 10.1186/1745-6215-10-52 – volume: 14 start-page: 89 year: 2014 ident: 1476_CR48 publication-title: BMC Health Serv Res doi: 10.1186/1472-6963-14-89 – volume: 12 start-page: 181 issue: 1 year: 2012 ident: 1476_CR11 publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-12-181 – volume: 307 start-page: 1199 issue: 6913 year: 1993 ident: 1476_CR38 publication-title: BMJ doi: 10.1136/bmj.307.6913.1199 – volume: 294 start-page: 2203 issue: 17 year: 2005 ident: 1476_CR33 publication-title: JAMA doi: 10.1001/jama.294.17.2203 – volume: 1 issue: 6 year: 2018 ident: 1476_CR22 publication-title: JAMA Netw Open doi: 10.1001/jamanetworkopen.2018.2969 – volume-title: Why we revolt: a patient revolution for careful and kind care: patient revolution year: 2017 ident: 1476_CR45 – volume: 340 start-page: c1066 year: 2010 ident: 1476_CR43 publication-title: BMJ doi: 10.1136/bmj.c1066 – volume: 61 start-page: 361 issue: 3 year: 2009 ident: 1476_CR35 publication-title: Arthritis Rheum doi: 10.1002/art.24279 – volume: 24 start-page: 240 issue: 1 year: 2018 ident: 1476_CR50 publication-title: J Eval Clin Pract doi: 10.1111/jep.12805 – ident: 1476_CR15 – volume: 4 start-page: 49 year: 2018 ident: 1476_CR49 publication-title: Res Involvement Engagement doi: 10.1186/s40900-018-0129-8
SSID	ssj0025774
Score	2.5513241
SecondaryResourceType	review_article
Snippet	Background Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to... Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to explore this... Background Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to... Background: Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed to... Abstract Background Participation in randomized controlled trials (RCTs) may be quite demanding and could represent an important burden for patients. We aimed...
SourceID	doaj pubmedcentral hal proquest gale pubmed crossref springer
SourceType	Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	6
SubjectTerms	Anxiety Biomedicine Clinical trials Codes Consent Cost of Illness Data collection Depression (Mood disorder) Economic aspects Finance Guinea pigs Humans Life Sciences Medical research Medicine Medicine & Public Health Methods Participation Patients Physiological aspects Psychological aspects Psychological research Public opinion Qualitative analysis Qualitative Research Quality assessment Randomization Randomized controlled trials Randomized Controlled Trials as Topic Research Article Research burden Santé publique et épidémiologie Trial participation Volunteers - psychology
SummonAdditionalLinks	– databaseName: Publicly Available Content Database dbid: PIMPY link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdYhxAvfH8EBhiEhASKareJ4_CCCmIa0jb1AdB4smzHppVGWppuD_z13DluSpjYE2-Rc3Uv8fk-4rvfEfKykqUuvZCpx64mWaFNqsGuQahSQNhTSFuG44Kvh8XxsTw5KaexPLqJaZUbnRgUdYv2jHnboISH1cLiF_MhgrSMIRaQ7N3yZ4o9pPCsNTbU2CG7CLzFBmR3-ulo-q0LwHLwdeLJJpdi2ICt4xhPlynPCpHmPdsUIPw7Rb0zwzzJi07oxVzKvw5Ug53av_l_n_AWuRH9VTppBew2ueLqO-TaUTyRv0uw8R2NiEEzakJRBF14CiawWvyY_3IVjdnwp3AZeoTQpf4jl_st1XQLJ003ILIwVsN1M29wtrb0M2CUUxf7oN4jX_Y_fv5wkMZ2Dqktxtk6NQax9LmwoEcMxxr2klXeuKriBqSl8hnXZiS1BC9Elr6Unru8rECUvB1Xko3vk0G9qN1DQqU2pYVIznHLMqeFNIWW3nHhmUMfKiFss5DKRqxzbLlxqkLMI4Vq114BFwrXXuUJed39ZNkCfVxG_B6loyNEjO4wsFh9V3HLK825GQtmGfc-G1Ue2AwemWdCG2ldQp6hbKm24LXTNGoiuCxG4PfxhLwKFKhrgH2rY8kEvARE7epR7vUoQUfY3u0XIL89dg8mhwrHEA1BFEyc4xwbuVRRkTVqK4YJed7dxukxOa92izOkybDgGrzFhDxod0P3V6Dh8xy82IQUvX3S46V_p57PAsy5KAt0fhPyZrOjtmz9c2UeXf4Qj8n1EX4wYRzMwx4ZrFdn7gm5as_X82b1NOqL32JCeaA priority: 102 providerName: ProQuest – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9QwDI_YQGgvfH8UBgSEhMRUkdy1ScrbgZj2MCYkYNpblKQJd9LWm663PfDXY6dpRxkgwVuVuDlf4jh2Y_9MyMtaVaYKQuUBq5oU0tjcwLkGrooEt0cqV8XrgsN9eXCgjo6qTymPu-2j3fsryaip47ZW4k0LJxNH77fKeSFFXm6QqyWCzaCL_vlw8LJKMGjS9eVvXxsdQBGnf9DGG3MMhrxsaV4OmPzl1jQeRrs3_-tv3CI3ku1JZ52w3CZXfHOHXP-YbtfvEixiRxP6z5zamOBAl4HCcVYvTxbffU1TZPsxPMZ6H_TU_BSX_ZYaegENTXtAWGhr4LldtDhal8YZ8capTzVN75Gvux--vN_LU2mG3Mlpsc6tRVx8LhzoBMsxH71idbC-rrmFla9DwY2dKKPAolBVqFTgvqxqEIvgprVi0_tks1k2_iGhytjKgVfmuWOFN0JZaVTwXATm0R7KCOvXS7uEW47lM4519F-U0N2UauBC45TqMiOvh1dOO9COvxG_QyEYCBFvOzYsV9902r7acG6ngjnGQygmdQA2o3UVmDBWOZ-RZyhCukteHbSGngmu5ARsOJ6RV5EC9Qaw70xKf4BJQASuEeX2iBL2uxt1vwAxHbG7N9vX2IbIBkIycY5j9FKsk1JqNSIbTcGBViwjz4duHB4D7Rq_PEOaApOnwfLLyINO6IefAm1dlmCRZkSOtsOIl3FPs5hHyHJRSTRkM7LTb4oLtv64Mo_-ifox2ZrgtxDGQfNvk8316sw_Idfc-XrRrp5GHfEDw79iXQ priority: 102 providerName: Springer Nature
Title	The research burden of randomized controlled trial participation: a systematic thematic synthesis of qualitative evidence
URI	https://link.springer.com/article/10.1186/s12916-019-1476-5 https://www.ncbi.nlm.nih.gov/pubmed/31955710 https://www.proquest.com/docview/2357314480 https://www.proquest.com/docview/2342358021 https://hal.science/hal-02546706 https://pubmed.ncbi.nlm.nih.gov/PMC6970283 https://doaj.org/article/a11b360c01ff42dfa6800078f06ab8ce
Volume	18
WOSCitedRecordID	wos000513668200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVADU databaseName: BioMedCentral customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: RBZ dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: DOA dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: M~E dateStart: 20030101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content (ProQuest) customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1741-7015 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0025774 issn: 1741-7015 databaseCode: RSV dateStart: 20031201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELfYQIgXxOcIjGIQEhIomt2m_uCtQ5uGtFXVgKk8WXZiq5VGOq3dHvjruXPcbGECXnipEvvquL7LfdTn3xHytlLa6iBUHrCqSSGtyy3YNQhVJIQ9UpU6bhecHMrxWE2nenKt1BfmhDXwwM3C7VjO3UCwkvEQin4VrFDRrgUmrFOlR-3LpF4HUynUGoJXk_YwuRI7S7BqHCNnnfNCinzYsUIRrL9VyRszzIi86W7ezJr8bes0WqT9B-R-ciXpqPkJD8ktXz8id4_SZvljgjXpaALzmVEXzyvQRaBgnarFj_lPX9GUqH4Kl7F8Bz2z19KsP1JLr5Ce6RrfFdpquF7OlzhacyozwodTn0qUPiHf9ve-fjrIU6WFvJSDYpU7hzD3XJTwijuOx8s1q4LzVcUdMLIKBbeur6wCB0HpoFXgfqgr4HIoB5Vig6dks17U_hmhyjpdQpDleckKD9xy0qrguQjMo3uTEbZeeVMmGHKshnFqYjiihGmYZWAWBpllhhl5337lrMHg-BvxLrKzJUT47NgAQmWSUJl_CVVGXqEwmOYsaqsEzEhwJfvgkvGMvIsUqAZg-qVNpxlgERBQq0O53aGE17fsdL8BgetM92B0aLANgQqEZOISx1jLo0k6ZmkQqGgA8bBiGXndduPwmDdX-8UF0hR4FhocuYxsNeLbPgqU73AIDmZGZEewO3Pp9tTzWUQgF1qiX5qRD-tX4Gpaf-TM8__BmRfkXh__8WAc9Ps22VydX_iX5E55uZovz3tkQ05l_FQ9cnt3bzw57kXFAHeTz0eT73B3_OXkFyikZTQ
linkProvider	Directory of Open Access Journals
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB61KQIuvB-GQhcEQgJZ9SbOeo2EUHhUiZpEORRUTst6vUsilSQkaRH8KH4jM34FU9FbD9ys9WQza8_OwzvzDcCTVMY6dkL6jrqahJFOfI12DUOVCMOeSJo4Oy742I-GQ3l4GI824FdZC0NplaVOzBR1OjP0jXyXYFla6P3L4PX8m09do-h0tWyhkYvFvv3xHUO25aveO3y_T5vNvfcHb7t-0VXAN1ErXPlJQpDuXBgU54RTKXUcpC6xacoTZDp1IddJU2qJxlDGLpaO23ac4oqcaaUyaOG8m7AVorAHDdga9QajT1WI10Zvqjg75VLsLtGacorYY5-HkfDbNeuXNQmoTMHmmDIxT7u5p7M1_zqyzSzh3tX_7RlegyuFz806-Sa5Dht2egMuDoqsgptAzftYgXo0ZklW2MFmjqEZT2dfJz9tyoqM_iO8zPqcsLn-Ix_9JdNsDYnNSiBcHJvi9XKypNny8tUMZ53ZopfrLfhwLgu_DY3pbGrvApM6iQ1Go5abILRayCTS0lkuXGDJD_QgKEVFmQKvndqGHKksbpNC5dKlkAtF0qXaHjyvfjLPwUrOIn5D8lcREs54NjBbfFGF2lKa86QlAhNw58Jm6pDNzKt0gdCJNNaDHZJelRftVtpSdQSXURN9V-7Bs4yC9CWyb3RR9oEPgZDHapTbNUrUc6Z2-zHukBq73U5f0RghOogoECc0Ryn5qlDGS7UWew8eVbdpekownNrZMdGEVDSOHq8Hd_L9Vv0VWql2Gz1xD6LaTqzxUr8znYwzqHYRR-TAe_Ci3LNrtv75Zu6dvYgduNQ9GPRVvzfcvw-Xm_QBKOBo7rahsVoc2wdwwZysJsvFw0I7Mfh83pv5NwB8y98
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYQBMvfMMCgxmEhMQULW4Tx-GtfFRDlGriY9qbZTs2rbSlVdPtgb-eO8fJCAMkxFvkXNyrc76P-O53hDwvRaEKx0XssKtJmisdK7BrEKrkEPbkwhT-uOBokk-n4vi4OAx9Tus22709kmxqGhClqVrvL0vXbHHB92uwUgwj4SJmac7jbINcTSGQwZyuT5-PuogrA-cmHGX-9rGeMfKY_Z1m3phhYuRlr_Ny8uQvJ6jeMI1v_vdfukVuBJ-Ujhohuk2u2OoO2foYTt3vEmxuRwMq0IxqX_hAF46CmSsXp_PvtqQh4_0ELn0fELpUP-Vrv6KKXkBG0xYoFsYquK7nNc7WlHd6HHJqQ6_Te-Tr-N2XNwdxaNkQm3yYrmOtES-fcQO6QjOsUy-S0mlblkyDRJQuZUoPhBLgaYjCFcIxmxUliIszw1Ikw_tks1pUdptQoXRhIFqzzCSpVVzoXAlnGXeJRT8pIkn77qQJeObYVuNE-rhGcNksqQQuJC6pzCLysntk2YB5_I34NQpER4g43H5gsfomw7aWijE95IlJmHPpoHTApve6XMKVFsZGZBfFSTZFrZ02kSPORD4A345F5IWnQH0C7BsVyiJgERCZq0e506MEPWB6t5-ByPbYPRhNJI4h4gHPE36Oc7QSLYOyqiUiHg0hsBZJRJ52t3F6TMCr7OIMaVIsqgaPMCIPmg3Q_RRo8SwDTzUieW9r9Hjp36nmMw9lzoscHdyI7LUb5IKtP76Zh_9EvUu2Dt-O5eT99MMjcn2An0sSBsZhh2yuV2f2MblmztfzevXEq44fT05uJQ
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+research+burden+of+randomized+controlled+trial+participation%3A+a+systematic+thematic+synthesis+of+qualitative+evidence&rft.jtitle=BMC+medicine&rft.au=Naidoo%2C+Nivantha&rft.au=Nguyen%2C+Van+Thu&rft.au=Ravaud%2C+Philippe&rft.au=Young%2C+Bridget&rft.date=2020-01-20&rft.pub=BioMed+Central&rft.eissn=1741-7015&rft.volume=18&rft_id=info:doi/10.1186%2Fs12916-019-1476-5&rft_id=info%3Apmid%2F31955710&rft.externalDocID=PMC6970283
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1741-7015&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1741-7015&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1741-7015&client=summon